Procalcitonin levels in migraine patients

Hale Turan1, Bahriye Horasanli, Murat Ugur

  • 1Department of Infectious Diseases and Clinical Microbiology Department, Baskent University Faculty of Medicine, Selçuklu, Konya, Turkey.

Abstract

Insights

Elevated procalcitonin (PCT) levels during migraine attacks suggest sterile inflammation plays a role in migraine pathogenesis. This finding may have implications for understanding migraine-related ischemic stroke risk.

Area of Science:

  • Neurology
  • Inflammation Research
  • Biomarker Discovery

Background:

  • Migraine is a recognized risk factor for ischemic stroke.
  • Sterile vascular inflammation is hypothesized to occur during migraine attacks.
  • Procalcitonin (PCT) is a marker for infection and sepsis, but also elevated in inflammatory conditions.

Purpose of the Study:

  • To investigate procalcitonin (PCT) levels in migraine patients.
  • To determine if PCT levels differ between migraine attack periods and inter-attack periods.
  • To explore the potential role of sterile inflammation in migraine pathogenesis.

Main Methods:

  • Eighty adult migraine patients were recruited.
  • Patients were grouped based on migraine attack status (during vs. inter-attack).
  • Further subgrouping was done based on aura status (with vs. without aura).

Main Results:

  • Average PCT levels were significantly higher in patients during migraine attacks compared to inter-attack periods (p<0.01).
  • Serum PCT levels were significantly elevated in patients with migraine without aura during attacks versus inter-attack periods (p<0.01).

Conclusions:

  • Significantly elevated PCT levels support the role of sterile inflammation in migraine pathogenesis.
  • Further research is needed to ascertain if PCT can serve as a marker for ischemic stroke risk in frequent migraine sufferers.